Diagnosing hearing loss at a fraction of the time and cost
September 14, 2011 in GeneticsOver 28 million Americans are hearing impaired, and 50 percent of these cases can be traced to genetic causes. The condition can be especially challenging for children born hearing impaired because spoken language, reading, and cognitive development are tied to hearing. That makes early diagnosis essential for identifying appropriate therapy and treatment.
Unfortunately, diagnosis for genetically caused hearing loss has traditionally been a slow and costly pursuit. A comprehensive genetic assessment for a deaf patient costs about $20,000 and takes years to complete. Now Prof. Karen Avraham of Tel Aviv University's Sackler Faculty of Medicine, in a unique collaboration with Prof. Moein Kanaan from Bethlehem University, has successfully developed a fast-track genetic diagnosis for hearing loss through "exome deep sequencing" a method that sequences hundreds of thousands of genes at a time.
Profs. Avraham and Kanaan studied a group of 11 Jewish Israelis and Palestinian Arabs, none of whom were related to each other but all of whom had deafness in their families. Using a technique called exome sequencing, which collects relevant DNA from specific sites of the body, they scanned 246 genes, ultimately identifying five mutations that lead to genetic hearing loss within the specified population. Reported in the journal Genome Biology, their method provides doctors with better diagnosis capabilities and can improve the quality of care for patients with hearing loss. For less than $500, researchers can scan all the known genes for deafness and provide results in a matter of weeks.
Tracing hereditary deafness
Though it is common to lose hearing as we age, three out of every 1,000 infants born in the U.S. are hearing impaired, and a third of these cases have hereditary causes. Although scientists have long searched for the genetic mechanisms underlying hearing loss, Prof. Avraham says it is a challenging task, noting that the critical genetic mutations that cause hearing impairment differ among populations, countries, and ethnicities.
Some of the mutations, says Prof. Avraham, have never before been identified in the Middle Eastern deaf population. This is the first time this technology has been applied to these populations, she says.
Better care on the horizon
The earlier hearing loss can be diagnosed, Prof. Avraham notes, the better care a patient will receive. More information about the genetic causes of a patient's hearing impairment enables doctors to better determine how it might progress, and to formulate treatment plans and rehabilitation options based on the challenges a patient might face.
In the past, doctors have been confined by methods of genetic analysis that are laborious, time consuming, and expensive. The number of mutations that scientists had the capacity to look for in any one patient was limited. Prof. Avraham's method allows doctors to identify the genetic cause of a patient's hearing loss in just a few weeks. And the more information researchers have about the genetic mutations that can cause hearing loss, says Prof. Avraham, the more likely that targeted and more effective treatments can be developed.
"It is a remarkable step forward in helping us to find treatments and even cures for patients. This new technology is changing the way we practice genomic medicine, and revolutionizing genetic diagnostics," she explains, noting that the technology can be applied to search for genetic mutations that characterize any disease or condition.
Provided by
Tel Aviv University
-
Scaling the wall of deafness
Apr 14, 2009 |
not rated yet |
0
-
New test can screen all deafness genes simultaneously
Nov 15, 2010 |
not rated yet |
0
-
Genes influence age-related hearing loss
Nov 14, 2007 |
not rated yet |
0
-
Many children with hearing loss also have eye disorders
Feb 16, 2009 |
not rated yet |
0
-
New mouse mutant contains clue to progressive hearing loss
Oct 31, 2008 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
20 hours ago |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Inherited DNA change explains overactive leukemia gene
A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.
Genetics
18 hours ago |
not rated yet |
0
|
'Personality genes' may help account for longevity
"It's in their genes" is a common refrain from scientists when asked about factors that allow centenarians to reach age 100 and beyond. Up until now, research has focused on genetic variations that offer a physiological advantage ...
Genetics
May 24, 2012 |
3 / 5 (1) |
0
|
Gene discovery points towards non-hormonal male contraceptive
A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.
Genetics
May 24, 2012 |
5 / 5 (5) |
0
|
Key gene found responsible for chronic inflammation, accelerated aging and cancer
Researchers at NYU School of Medicine have, for the first time, identified a single gene that simultaneously controls inflammation, accelerated aging and cancer.
Genetics
May 24, 2012 |
not rated yet |
0
Knowing genetic makeup may not significantly improve disease risk prediction
Harvard School of Public Health (HSPH) researchers have found that detailed knowledge about your genetic makeupthe interplay between genetic variants and other genetic variants, or between genetic variants and environmental ...
Genetics
May 24, 2012 |
2 / 5 (1) |
0
|
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Tongue analysis software uses ancient Chinese medicine to warn of disease
For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...
Cancer may require simpler genetic mutations than previously thought
Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...
Skp2 activates cancer-promoting, glucose-processing Akt
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare
A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...
New device allows pacemaker patients to safely undergo MRIs
For many, it's a medical conundrum: The very pacemaker keeping their heart in rhythm prevents them from undergoing an MRI to diagnose other ailments, because interaction between the two devices could prove deadly.
Sep 15, 2011
Rank: not rated yet
I would be curious to know if these treatments do exist!
so why take people for idiots talking treatment in 3 weeks and blabla
If the discovery is interesting, but I hope it is real and useful!
For 50 years we haven't yet found a single drug for this problem! I wonder where's he going to spend money on research! or so we are incompetent!
Even for the hearing despite the technological advances we hear, we come not to make an effective and totally indiscreet prosthesis with reasonable autonomy (eg one week)